Virbac

VIRP.PA Mid Cap

Healthcare · Drug Manufacturers - General

Updated: Apr 5, 2026, 17:43 UTC

€351.00

-0.85% today

52W: €249.70 – €373.50

52W Low: €249.70 Position: 81.8% 52W High: €373.50

🔗 Compare Brokers

Key Metrics

P/E Ratio

19.49x

Price-to-Earnings

Forward P/E

15.24x

Forward Price/Earnings

P/S Ratio

2.01x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

41%

Annual dividend yield

Market Cap

$2.9B

Market Capitalization

Revenue Growth

4.6%

YoY Revenue Growth

Profit Margin

10.3%

Net profit margin

ROE

13.88%

Return on Equity

Beta

0.81

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

5,218

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

9 analysts

Avg. Price Target

€413.00

+17.66% upside

Target Range

€368.00 – €440.00

About the Company

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.

Sector: Healthcare Industry: Drug Manufacturers - General Country: France Exchange: PAR